NO940226D0 - Chirale mellomprodukter for fremstilling av antidiabetiske tiazol er - Google Patents

Chirale mellomprodukter for fremstilling av antidiabetiske tiazol er

Info

Publication number
NO940226D0
NO940226D0 NO940226A NO940226A NO940226D0 NO 940226 D0 NO940226 D0 NO 940226D0 NO 940226 A NO940226 A NO 940226A NO 940226 A NO940226 A NO 940226A NO 940226 D0 NO940226 D0 NO 940226D0
Authority
NO
Norway
Prior art keywords
antidiabetic
thiazole
preparation
chiral intermediates
chiral
Prior art date
Application number
NO940226A
Other languages
English (en)
Norwegian (no)
Other versions
NO940226L (no
Inventor
George Joseph Quallich
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO940226L publication Critical patent/NO940226L/no
Publication of NO940226D0 publication Critical patent/NO940226D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO940226A 1991-07-22 1994-01-21 Chirale mellomprodukter for fremstilling av antidiabetiske tiazol er NO940226D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73354891A 1991-07-22 1991-07-22
PCT/US1992/005434 WO1993002061A1 (en) 1991-07-22 1992-07-01 Chiral intermediates for the preparation of antidiabetics thiazoles

Publications (2)

Publication Number Publication Date
NO940226L NO940226L (no) 1994-01-21
NO940226D0 true NO940226D0 (no) 1994-01-21

Family

ID=24948077

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940226A NO940226D0 (no) 1991-07-22 1994-01-21 Chirale mellomprodukter for fremstilling av antidiabetiske tiazol er

Country Status (17)

Country Link
US (1) US5576442A (pt)
EP (1) EP0641331A1 (pt)
JP (1) JP2672029B2 (pt)
KR (1) KR100214907B1 (pt)
AU (1) AU660187B2 (pt)
CA (1) CA2111446C (pt)
FI (1) FI940307A (pt)
HU (1) HUT70422A (pt)
IE (1) IE922358A1 (pt)
IL (1) IL102575A (pt)
MX (1) MX9204277A (pt)
NO (1) NO940226D0 (pt)
NZ (1) NZ243652A (pt)
PT (1) PT100709B (pt)
TW (1) TW199892B (pt)
WO (1) WO1993002061A1 (pt)
ZA (1) ZA925470B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687149B1 (fr) * 1992-02-12 1995-11-03 Roussel Uclaf Nouveaux esters pyrethrinouides derives d'alcools thiazoliques, leur procede de preparation et leur application comme pesticides.
EP0708764A1 (en) * 1993-07-16 1996-05-01 Pfizer Inc. Enanthioselective preparation of thiazole derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US4886814A (en) * 1986-03-13 1989-12-12 Dr. Karl Thomas Gmbh Substituted thiazoles and oxazoles and 2-hydroxy-morpholines
US4943635A (en) * 1987-08-27 1990-07-24 President & Fellows Of Harvard College Enantioselective reduction of ketones
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
EP0595868B1 (en) * 1991-07-22 1998-11-25 Pfizer Inc. Process for the preparation of (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl]bromobenzene

Also Published As

Publication number Publication date
IL102575A0 (en) 1993-01-14
FI940307A0 (fi) 1994-01-21
IL102575A (en) 1996-03-31
PT100709A (pt) 1993-09-30
FI940307A (fi) 1994-01-21
NZ243652A (en) 1994-02-25
JPH06505026A (ja) 1994-06-09
ZA925470B (en) 1994-01-21
CA2111446C (en) 1997-12-16
WO1993002061A1 (en) 1993-02-04
NO940226L (no) 1994-01-21
EP0641331A1 (en) 1995-03-08
US5576442A (en) 1996-11-19
MX9204277A (es) 1993-02-01
KR100214907B1 (ko) 1999-08-02
TW199892B (pt) 1993-02-11
IE922358A1 (en) 1993-01-27
AU660187B2 (en) 1995-06-15
HU9400187D0 (en) 1994-05-30
HUT70422A (en) 1995-10-30
JP2672029B2 (ja) 1997-11-05
AU2306392A (en) 1993-02-23
PT100709B (pt) 1999-07-30
CA2111446A1 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
FI954768A (fi) Välituotteina käyttökelpoiset 4-syklopropyylimetoksipyridiiniyhdisteet
FI104170B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi
FI905941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
DK0658161T3 (da) Substituerede thiazolidindionderivater
LV5779A4 (lv) Tiazolidindiona atvasinajumi ar antidiabetiskam ipasibam
NO912411D0 (no) Fremgangsmaate for fremstilling av bicykliske heterocykliske forbindelser.
NO914027D0 (no) Fremgangsmaate for fremstilling av nye substituerte azetidinoner
FI940769A0 (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
FI960254A0 (fi) Menetelmä N-(4-hydroksifenyyli)-retiiniamidin valmistamiseksi
EE9400257A (et) Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks
FI98461B (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
NO940226D0 (no) Chirale mellomprodukter for fremstilling av antidiabetiske tiazol er
MX9102186A (es) Derivados de aminodiol
MX9100049A (es) Derivados de aminodiol
NO306594B1 (no) Fremgangsmåte for fremstilling av en semduramicin-forblanding
NO914577D0 (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser
NO923290L (no) Fremgangsmaate for fremstilling av metylacetat
BR9306924A (pt) Derivados de 1,3-oxazolidina pirdil-substituídos oidetos de 1,2,4-ditioz lio de novos compostos de partida
FI940338A (fi) Menetelmä 13alfa-sinnamoyylibakkatiini III:n tai -10-desasetyylibakkatiini III:n valmistamiseksi
FI960180A0 (fi) Tiatsolijohdannaisten enantioselektiivinen valmistus
NO177592C (no) Nye mellomprodukter for fremstilling av carbapenemderivater
NO920033D0 (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser
NO176760C (no) Mellomprodukter for fremstilling av imidazopyridaziner
NO950203L (no) Fremgangsmåte for fremstilling av propargylazetidion-forbindelser